GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Animal Biotechnology Market, By Product Type (Diagnostics Tests, Vaccines, Drugs, Reproductive and Genetic, Feed Additives, Others), By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others), By Animal Type (Companion, Livestock), By End User (Veterinary Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Animal Biotechnology Market- Recent Developments

Product Approval

On November 20, 2023, the U.S. Food and Drug Administration (FDA) had approved a number of animal drugs including those that treat Giardia duodenalis in dogs and bacterial enteritis in replacement beef and dairy heifers
- Ayradia for dogs, on October 11, 2023, the U.S. FDA approved Ayradia, a metronidazole oral suspension, for the treatment of Giardia duodenalis infection in dogs. Ayradia is the first U.S. FDA-approved animal drug for treating Giardia duodenalis infections (Manufactured by Virbac AH, Inc., an animal health pharmaceutical company).
- Aivlosin for female swine: On October 13, 2023 the U.S. FDA approved Aivlosin Water Soluble Granules (WSG) - 62.5% w/w tylvalosin as tylvalosin tartrate - for female swine intended for breeding such as replacement gilts, gestating replacement gilts, gestating sows, lactating sows, and weaned sows
- Estroplan for dairy cows: On September 20, 2023, the U.S. FDA approved Estroplan, an injectable cloprostenol solution for dairy cows. This supplement is indicated for use with gonadorelin to synchronize estrous cycles to allow for fixed time artificial insemination in lactating dairy cows.

Business Development Activities

On June 26, 2023, the Chief Animal Husbandry Officer India, Leh, Indian-administered Ladakh in the disputed Kashmir region, launched the third phase of Foot and Mouth Disease (FMD) vaccination under the National Animal Disease Control Program (NADCP) on June 23, 2023. The primary objective of the NADCP is to control the spread of FMD in cattle by implementing widespread vaccination programs. The program aims to achieve effective control of FMD by 2025 and ultimately eradicate the disease by 2030. The online vaccination data will be updated by the officials carrying out vaccination in the field and will be reflected on Bharat Pashudan or National Digital Livestock Mission (NDLM) portal and the farmer friendly e-Gopala App.
In April 2022, Cadila Pharmaceuticals, a pharmaceutical company, announced that it had developed first novel three-dose vaccine against rabies. The three-dose vaccine, named as 'ThRabis', is a recombinant nano-particle-based G protein vaccine, which is prepared using virus-like particle technology.